focus -WSS

focus

author：hotspot 2025-09-06 04:41:02 - browse：6785

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Padmanee Sharma of MD Anderson at center of lawsuit over credit

explore

WSS

Medicare drug price negotiation hearing pits pharma v Biden admin

He's 19 months old and has one of the world’s rarest diseases

Longer MASH drug regimen improved liver, Akero study finds

Bernie brings in new pharma CEOs to talk drug prices

Immune cells and nerve overgrowth may explain recurring UTI pain

Longer MASH drug regimen improved liver, Akero study finds

knowledge

focus

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: BridgeBio, Akero, and human embryo models

Continuity nursing helped my family in our darkest PICU moments

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Dobbs anniversary: the lost opportunity of abortion as health care

Microsoft's Peter Lee: Generative AI could help doctors be more human

Anesthesiologist group: stop taking Ozempic before surgery

Harvard's David Sinclair gets blowback over aging

Guidelines to prevent youth baseball injuries need more muscle

Texas Medical Board asked to define abortion emergency exception

leisure time

Florida health officials providing scant details on measles cases

Pregnant women don't need prenatal multivitamins, study concludes

Change Healthcare: What is it, why does its cyberattack matter?

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Cano Health’s bankruptcy is a warning for Medicare Advantage

Unique patient identifier: Experts argue the benefits, pitfalls

knowledge

entertainment

explore

entertainment